Histogen shares are trading lower after the company announced its Board of Directors approved a Plan of Dissolution.
Portfolio Pulse from Benzinga Newsdesk
Histogen has announced that its Board of Directors approved a Plan of Dissolution, leading to a drop in the company's share price.
September 19, 2023 | 2:31 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Histogen's shares are trading lower after the company's Board of Directors approved a Plan of Dissolution.
The approval of a Plan of Dissolution by Histogen's Board of Directors indicates that the company is planning to dissolve, which is a negative signal for investors. This has led to a decrease in the company's share price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100